Graduate School of Comprehensive Human Sciences,1 Center for Tsukuba Advanced Research Alliance,2 ERATO Environmental Response Project, University of Tsukuba, Tsukuba 305-8577,3 Research Center for Advanced Science and Technology, University of Tokyo, Tokyo 153-8904, Japan,4 Department of Cell and Developmental Biology and Center for Organogenesis, University of Michigan, Ann Arbor, Michigan 48109-06165
Received 6 August 2004/ Returned for modification 1 October 2004/ Accepted 5 July 2005
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
The GC residues of the ARE (underlined above), which flank the TRE (TPA-response element) core sequence [TGA(G/C)TCA] of MARE, are critical for the induction of genes in response to oxidative stimuli (38). Furthermore, a recent nuclear magnetic resonance structural analysis suggested that the small Maf proteins contact the GC sequence in the MARE (or ARE) using a unique DNA binding motif termed the extended homology region, which is located N terminal to the basic region-leucine zipper (bZIP) motif (18, 20). Hence, the small Maf proteins are generally regarded as important components of the cellular stress response mediated through the cis-acting ARE elements. Since typical MAREs contain a central TRE, bZIP-type transcription factors, including Jun, Fos, and ATF family proteins, may also bind to MAREs and their related sequences and may affect transcriptional responses through these elements (15).
The biological significance of ARE-binding transcription factors has also been examined and confirmed by germ line genetic manipulation. Analysis of nrf2-null mutant mice showed that Nrf2 is a central regulator of the induction of many antioxidant-responsive genes and phase II detoxification enzyme genes and that Nrf2 is a key transcriptional activator of AREs (6, 8). Under normal physiological conditions, Nrf2 is captured in the cell cytoplasm by a molecule called Keap1 and turned over rapidly by proteasomal degradation (10, 11, 24, 33, 41). However, in response to oxidative stress, Nrf2 is stabilized, relocates to the nucleus, and binds to and activates target response genes (10, 11). As part of the proof elucidating this pathway, it was shown that Nrf2 accumulates in the nuclei of keap1-null mutant mice even in the absence of exogenous stress stimuli, leading to constitutive activation of ARE-dependent genes (43). Analysis of single nrf1-null mice and nrf1::nrf2 compound mutant mice suggests that Nrf1 also contributes to the induction of ARE-dependent genes (22).
Many studies have attempted to clarify the contribution of the small Maf proteins to ARE-dependent gene regulation. To date, no clear functional differences have been reported among the three small Maf proteins MafG, MafK, and MafF (29). Unlike their CNC and Bach partner molecules, canonical functional domains other than the DNA binding and dimerization motifs have not been identified in these small Maf proteins (29). Published studies have led to the conclusion that the CNC and Bach proteins require small Maf proteins as obligatory partners to promote site-specific ARE/MARE association (1, 2, 7, 19, 25, 37). One interpretation of these data is that the small Maf proteins contribute to transcriptional activation and repression as a consequence of the intrinsic activities of their heterodimeric partners (the CNC and Bach proteins). However, it is well documented that the small Maf proteins form homodimers, which can act as repressive competitors for MAREs with large Maf homodimers, as well as with small Maf-CNC heterodimers (28). In contrast to this view of small Maf contributions to MARE-mediated gene activation, several reports describe evidence that led their authors to conclude that the small Maf proteins contribute exclusively to the repression of ARE-dependent genes and not to their activation (3, 14, 32). In summary, according to divergent interpretations of biochemical, transfection, and in vivo data, it is clear that the contribution of the small Maf proteins to transcriptional activation and repression through ARE elements has not been definitively resolved.
To address the function of the small Maf proteins in vivo, we originally reported their individual germ line disruptions in mice (35, 36, 39). Although mafF/ (F0) and mafK/ (K0) mice displayed no apparent mutant phenotypes, mafG-null mutant mice displayed mild thrombocytopenia accompanied by a late-onset neurological disorder (39). The neurological abnormality was exacerbated in mafG/::mafK+/ (G0K1) compound mutant mice, suggesting that MafG and MafK share compensatory functions in the central nervous system (16). Since several neurodegenerative disorders are suspected to result from a dysregulated oxidative stress response, we analyzed the expression of ARE-dependent genes in the central nervous systems of these symptomatic mutant mice. These studies showed that the heme oxygenase 1 gene (HO-1) was induced in G0K1 compound mutant animals, whereas many other ARE-dependent genes were not significantly affected (16). We also found that Bach proteins failed to accumulate in neuronal nuclei in the G0K1 central nervous system, which could explain the observed HO-1 transcriptional derepression (16, 42). However, these studies did not resolve whether or not the small Maf proteins collaboratively, with a CNC partner, contribute to the activation of ARE-dependent genes. Here, we provide direct and decisive genetic evidence that the small Maf proteins are required for the activation of ARE-dependent gene expression collaboratively with Nrf2 in vivo, thereby excluding the notion that the small Maf proteins contribute merely to ARE-mediated repression.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Mouse embryonic fibroblasts (MEFs). MEFs were prepared from individual embryos at embryonic day 11.0 (E11.0) or E13.5. The head and internal organs were removed, and the torso was minced and dispersed in 0.25% trypsin-EDTA. MEFs were maintained in Dulbecco's modified Eagle's medium (Sigma Chemical Co., St. Louis, Mo.) containing 10% fetal bovine serum and antibiotics.
Cell viability analysis. MEFs prepared from mafG+/+::mafK/::mafF/ (G2K0F0) and mafG/::mafK/::mafF/ (G0K0F0) embryos were seeded at an initial density of 5 x 103 cells/well in 96-microwell plates. Cells were initially cultured in 25 µM diethyl maleate (DEM). After 24 h, the medium was replaced with medium containing 0, 5, or 10 µM 1-chloro-2,4-dinitrobenzene (CDNB; Wako Pure Chemicals, Osaka, Japan). After 12 h of culturing, a cell viability assay (Cell Counting Kit-8; Dojindo Molecular Technologies, Inc., Kumamoto, Japan) was used to measure the activities of dehydrogenase enzymes as an indicator of cell viability according to the manufacturer's protocol.
RNA extraction. Total RNA was prepared from mouse liver or mouse embryonic fibroblasts using an Isogen RNA extraction kit (Nippon Gene, Toyama, Japan) and following the manufacturer's protocol.
RNA blot analysis. Purified total RNA was electrophoresed on formaldehyde-agarose gels and transferred onto a nylon membrane (Zeta Probe membrane; Promega). 32P-labeled probes were prepared from the cDNA by random primer labeling. cDNAs encoding HO-1 and NQO1 were previously described (6, 8). cDNA that can detect both glutathione S-transferase P1 (GSTP1) and GSTP2 mRNAs was a gift from Kimihiko Satoh (Hirosaki University School of Medicine, Hirosaki, Japan) and designated GSTP1/2. To generate the probes, cDNA fragments were amplified by PCR using various primer pairs as follows: 5'-CAG TGT TTG AAC GGA ACA GA-3' and 5'-TAC TTG GTC CAA GAC TTG AC-3' for the ferritin light chain (FTL) gene, 5'-ATG TAT GCA GAT GGC ACC CAG GAC CTG-3' and 5'-GGA CAA TCC TGA CCA CCT CAA CAT AG-3' for the GSTA4 gene, and 5'-GAA GAC CCT AGT AGT TGG TGC ATC-3' and 5'-AAG GAG TAA ATA CAG TCG TTG GGA C-3' for the thioredoxin reductase 1 gene (TXNRD1). The PCR products were subcloned into the pGEM-T easy vector (Promega).
Administration of butylated hydroxyanisole (BHA) to mice. BHA (Sigma Chemicals) was administered by oral gavage at a dose of 0.6 g/kg dissolved in corn oil. Animals were sacrificed 24 h after treatment, and livers were processed for the purification of RNA. All mice used in this analysis were 10- to 15-week-old females.
cDNA microarray analysis. Isolated total RNA was further purified by RNeasy RNA isolation kit (QIAGEN) by following the manufacturer's protocol. The purified RNA was processed and hybridized to a mouse expression array 430A gene chip (Affymetrix, Santa Clara, CA). Experimental procedures for GeneChip were performed according to the Affymetrix Gene Chip Expression Analysis technical manual.
Quantitative real-time PCR. cDNA was synthesized from the isolated RNAs by reverse transcriptase using random hexamer oligonucleotide primers, and real-time PCR was performed using an ABI Prism 7700 (Applied Biosystems, Foster City, CA) as previously described (35). The primer and probe sequences used for detecting NQO1, GSTA4, TXNRD1, glutamate-cysteine ligase catalytic subunit (GCLC), and HO-1 mRNAs are shown in Table 1. The rRNA primers and probes were purchased from Applied Biosystems.
|
| RESULTS |
|---|
|
|
|---|
|
We generated two lines of compound keap1-null mutant mice, keap1/::mafG/::mafF/ (Kp0G0F0) and keap1/::nrf2/ (Kp0N0). Since keap1-null mutant pups die before weaning, the expression of ARE-dependent genes was examined in the livers of mice at postnatal day 10. As previously documented (43), multiple ARE-dependent genes were constitutively induced in the keap1-null mutant mice (Kp0) and the induction was fully abrogated in Kp0N0 compound mutant mice (Fig. 2), confirming that ARE-dependent gene activation in the absence of Keap1 is completely dependent on Nrf2. However, in the Kp0G0F0 mutant mice, only NQO1 and TXNRD1 induction was partially decreased, while GSTP1/2 and FTL were essentially unaffected by the absence of the small Maf proteins (Fig. 2). Taken together, these results demonstrate that the expression of MafG and/or MafF is indispensable for the induction of the NQO1 and TXNRD1 genes through the Nrf2-ARE pathway, while the GSTP1/2 and FTL genes are not sensitive to the loss of both MafG and MafF. Two possibilities were raised regarding the regulation of the GSTP1/2 and FTL genes. One is that the remaining small Maf protein, MafK, is sufficient for the Nrf2-mediated activation of the latter genes. The other possibility is that bZIP proteins apart from small Maf proteins cooperate with Nrf2 and activate these genes.
|
|
We selected a pair of fibroblasts with the G2K0F0 (mafG+/+::mafK/::mafF/) and G0K0F0 genotypes. To determine whether the G2K0F0 fibroblasts represent an appropriate reference for the gene expression analysis of G0K0F0 cells, we analyzed and compared the sensitivities of these cells to oxidative stress. These cells were incubated for 12 h with 0, 5, and 10 µM CDNB, which is known to act as a strong oxidative stress agent (6). When we recorded an indirect measure of cell viability, the differences in cell viability that represented sensitivity to CDNB toxicity were insignificant in MEFs with the G2K0F0 or G0K0F0 genotype (Fig. 4).
|
Microarray analysis documents the broad contribution of small Maf proteins to ARE-dependent gene transcription. To comprehensively examine the effect of a complete loss of small Maf proteins on gene regulation, we exploited oligonucleotide microarrays and analyzed the expression of genes that are inducible by DEM in MEFs with the genotype G2K0F0 or G0K0F0. These fibroblasts were treated with DEM or a vehicle control, followed by RNA extraction for probe processing. In this analysis, we focused on the genes encoding drug-metabolizing enzymes and antioxidant enzymes, as these genes seem to play important roles in the acquisition of cellular resistance to oxidative stress. We found that in G2K0F0 cells, DEM treatment induced a number of genes coding for chaperone-related proteins, drug-metabolizing enzymes, and antioxidant enzymes (Table 2). A detailed comparison of the results obtained with the previous microarray analyses utilizing nrf2-null mice and nrf2::keap1 compound mutant mice (6, 21) revealed that many of the DEM-inducible genes in G2K0F0 mice were identified as the genes whose expression is heavily dependent on Nrf2 (Table 2).
|
Deficiency of small Maf proteins affects the electrophile-mediated induction of gene expression. To verify the microarray results and to gain further insights into the small Maf contribution to the expression of genes induced by electrophiles, we examined the expression of several pertinent genes by quantitative reverse transcription-PCR analyses. In the analyses, in addition to the triple-null mutant MEFs (G0K0F0), we newly adopted G0K0F1 (mafG/::mafK/::mafF+/) cells that contain only one copy of MafF, expecting the lowest expression of small Maf activity, and compared the gene expression profile of the cells with that of G2K0F1 (mafG+/+::mafK/::mafF+/) cells. Consistent with the microarray data, G0K0F0 cells showed no apparent induction of the NQO1, GSTA4, TXNRD1, or GCLC gene (Fig. 5, lower panels). The HO-1 gene was similarly derepressed in both the basal and induced states, and no induction was observed anymore in G0K0F0 fibroblasts (Fig. 5, lower right panel). In the presence of one mafF allele (G0K0F1 cells versus G2K0F1 cells), the loss of MafG did not affect significantly the induction of the GSTA4, GCLC, and TXNRD1 genes and decreased and increased moderately the induction of the NQO1 and HO-1 genes, respectively (Fig. 5, upper panels). These results strongly support our contention that MafF functionally compensates the lack of MafG and MafK. In summary, we conclude that the small Maf proteins are essential for the induction of multiple ARE-dependent genes encoding xenobiotic-metabolizing enzymes and antioxidant enzymes.
|
| DISCUSSION |
|---|
|
|
|---|
Our group and others have documented that the small Maf proteins act cooperatively with p45 NF-E2 to activate target genes in megakaryocytes (28, 36, 40). Therefore, heterodimers of the other CNC family (Nrf1, Nrf2, and Nrf3) and small Maf proteins were anticipated to act as transcriptional activators as well. However, cell culture studies have shown that small Maf proteins can behave as negative regulators of Nrf2-dependent reporter gene activation (3, 32). To definitively address whether or not the Nrf2 and small Maf proteins act as cooperative transcriptional activators in vivo, we examined the expression of ARE-dependent genes in small Maf and other (keap1 and nrf2) mutant mice whose biochemical pathways hypothetically intersect. The prediction of these experiments was that if CNC-small Maf heterodimers positively regulate transcription, the induction of Nrf2-dependent genes should be diminished in small maf mutant mice, as well as in nrf2 mutant mice. In contrast, if the small Mafs contribute only to negative regulation through AREs, a loss of small Maf activity would be expected to confer an activation phenotype.
In this study, we first examined G0F0 mice to prove the contribution of small Maf proteins in vivo. We failed to observe any significant effects of small Maf reduction on the abundance of ARE-dependent genes other than NQO1 and TXNRD1. When G0K0F0 fibroblasts lacking all three small Maf proteins were established and examined, we finally observed a complete loss of induction in almost all of the Nrf2-dependent genes induced in this analysis. Intriguingly, many of the ARE-dependent genes, with a few exceptions, responded to electrophilic reagents in G2K0F0 cells and G0K0F1 cells, as well as in G0F0 (G0K2F0) mouse livers. This implies that each single small Maf protein is more or less capable of supporting Nrf2-mediated transcriptional activation. This is the first report that genetically demonstrates the ability of each small Maf protein to contribute to ARE-dependent gene activation and the essential roles of the family of small Maf proteins in the activation.
Strictly speaking, in this study, we could evaluate the contribution of small Maf proteins only in relation to inducible ARE-dependent genes in fibroblasts. Since GSTP1/2 and FTL were not significantly induced in fibroblasts, it was still possible that in the liver the GSTP1/2 and FTL genes are regulated in an Nrf2-dependent and Maf-independent manner. Indeed, it has been reported that Nrf2 heterodimerizes with c-Jun (13) and ATF4 (5). In contrast, a comprehensive analysis of all possible protein-protein interactions was recently reported using a protein array that was fabricated with an almost complete set of coiled-coil domains of all the human bZIP transcription factors. The data revealed that the binding affinities between the small Maf and CNC proteins were much stronger than those between CNC proteins and c-Jun or ATF4 (31). This result leads us to believe that small Maf proteins are substantial partners of Nrf2 and that induction of GSTP1/2 and FTL in a G0F0 background was maintained by Nrf2-MafK heterodimer. Nonetheless, it remains an open question whether or not Nrf2-c-Jun or Nrf2-ATF4 heterodimers might be able to functionally compensate for Nrf2-Maf loss in vivo. Simultaneous disruption of keap1 and c-jun or ATF4 may provide unique insights into this issue. In any case, our present data rejected the notion that the small Maf proteins contribute exclusively to ARE-mediated repression.
Since we here provide genetic evidence that small Maf proteins are essential for the ARE-dependent genes, it might be possible that small Maf proteins are essential for DNA binding of Nrf2 and/or for other processes, including the localization and stabilization of Nrf2. We previously reported that the nuclear localization of Bach proteins is dependent on small Maf proteins (16). Since Bach proteins possess a nuclear export signal (NES), we surmised that small Maf proteins prevent Bach proteins from being exported from nuclei by the NES binding protein CRM1 (exportin 1). Recently, a NES has been identified in the leucine zipper motif of Nrf2 (12, 23), which suggests the possibility that the nuclear accumulation of Nrf2 is also influenced by small Maf proteins.
In conclusion, we have provided evidence that a genetic reduction in the abundance of small Maf proteins has a great influence on the expression of a wide range of ARE-dependent genes. Our in vivo experiments utilizing small maf double-mutant mice also implied the differential contribution of small Maf proteins to the expression of ARE-dependent genes. For instance, the NQO1 gene seems to be more sensitive to the reduction of small Maf proteins compared to several other ARE-dependent genes. We envisage that the differential requirement of small Maf proteins might be attributed to the variation in the ARE and its flanking sequence of each gene, which might result in the differential affinity for the activator complex containing Nrf2-small Maf heterodimer (34). However, we could not find a clear correlation between the sensitivity to the reduction in small Mafs and the ARE sequence variations. We also surmise that such a differential threshold might enable small Maf proteins, by virtue of a change in their abundance, to differentially regulate specific ARE-dependent genes. Since the abundance of small Maf proteins has been reported to fluctuate in response to oxidative stress (17, 26), the intriguing possibility emerges that the small Maf proteins may generate diversity in Nrf2-mediated gene regulation by changing their abundance.
| ACKNOWLEDGMENTS |
|---|
This work was supported by grants from the NIH (CA80088 and GM28896 to F.K., H.M., and J.D.E.), ERATO-JST (M.Y.), the Ministry of Education, Science, Sports and Culture (H.M. and M.Y.), the Atherosclerosis Foundation (M.Y.), the Yamanouchi Foundation for Research on Metabolic Disorders (H.M.), and the Uehara Memorial Foundation (H.M.). F.K. is a JSPS Research Fellow.
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
2. Chan, J. Y., X. L. Han, and Y. W. Kan. 1993. Cloning of Nrf1, an NF-E2-related transcription factor, by genetic selection in yeast. Proc. Natl. Acad. Sci. USA 90:11371-11375.
3. Dhakshinamoorthy, S., and A. K. Jaiswal. 2000. Small maf (MafG and MafK) proteins negatively regulate antioxidant response element-mediated expression and antioxidant induction of the NAD(P)H:quinone oxidoreductase1 gene. J. Biol. Chem. 275:40134-40141.
4. Hayes, J. D., J. U. Flanagan, and I. R. Jowsey. 2005. Glutathione transferases. Annu. Rev. Pharmacol. Toxicol. 45:51-88.[CrossRef][Medline]
5. He, C. H., P. Gong, B. Hu, D. Stewart, M. E. Choi, A. M. Choi, and J. Alam. 2001. Identification of activating transcription factor 4 (ATF4) as an Nrf2-interacting protein. Implication for heme oxygenase-1 gene regulation. J. Biol. Chem. 276:20858-20865.
6. Ishii, T., K. Itoh, S. Takahashi, H. Sato, T. Yanagawa, Y. Katoh, S. Bannai, and M. Yamamoto. 2000. Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J. Biol. Chem. 275:16023-16029.
7. Itoh, K., K. Igarashi, N. Hayashi, M. Nishizawa, and M. Yamamoto. 1995. Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins. Mol. Cell. Biol. 158:4184-4193.
8. Itoh, K., T. Chiba, S. Takahashi, T. Ishii, K. Igarashi, Y. Katoh, T. Oyake, N. Hayashi, K. Satoh, I. Hatayama, M. Yamamoto, and Y. Nabeshima. 1997. An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem. Biophys. Res. Commun. 236:313-322.[CrossRef][Medline]
9. Itoh, K., T. Ishii, N. Wakabayashi, and M. Yamamoto. 1999. Regulatory mechanisms of cellular response to oxidative stress. Free Radic. Res. 31:319-324.[Medline]
10. Itoh, K., N. Wakabayashi, Y. Katoh, T. Ishii, K. Igarashi, J. D. Engel, and M. Yamamoto. 1999. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 13:76-86.
11. Itoh, K., N. Wakabayashi, Y. Katoh, T. Ishii, T. O'Connor, and M. Yamamoto. 2003. Keap1 regulates both cytoplasmic-nuclear shuttling and degradation of Nrf2 in response to electrophiles. Genes Cells 8:379-391.[Abstract]
12. Jain A. K., D. A. Bloom, and A. K. Jaiswal. 17 May 2005. Nuclear import and export signals in control of NRF2. J. Biol. Chem. doi:10.1074/jbc.M502083200.
13. Jeyapaul, J., and A. K. Jaiswal. 2000. Nrf2 and c-Jun regulation of antioxidant response element (ARE)-mediated expression and induction of
-glutamylcysteine synthetase heavy subunit gene. Biochem. Pharmacol. 59:1433-1439.[CrossRef][Medline]
14. Johnsen, O., P. Murphy, H. Prydz, and A. B. Kolsto. 1998. Interaction of the CNC-bZIP factor TCF11/LCR-F1/Nrf1 with MafG: binding-site selection and regulation of transcription. Nucleic Acids Res. 26:512-520.
15. Kataoka, K., M. Noda, and M. Nishizawa. 1994. Maf nuclear oncoprotein recognizes sequences related to an AP-1 site and forms heterodimers with both Fos and Jun. Mol. Cell. Biol. 14:700-712.
16. Katsuoka, F., H. Motohashi, Y. Tamagawa, S. Kure, K. Igarashi, J. D. Engel, and M. Yamamoto. 2003. Small Maf compound mutants display central nervous system neuronal degeneration, aberrant transcription, and Bach protein mislocalization coincident with myoclonus and abnormal startle response. Mol. Cell. Biol. 23:1163-1174.
17. Katsuoka, F., H. Motohashi, J. D. Engel, and M. Yamamoto. 2005. Nrf2 transcriptionally activates the mafG gene through an antioxidant response element. J. Biol. Chem. 280:4483-4490.
18. Kerppola, T. K., and T. Curran. 1994. A conserved region adjacent to the basic domain is required for recognition of an extended DNA binding site by Maf/Nrl family proteins. Oncogene 9:3149-3158.[Medline]
19. Kobayashi, A., E. Ito, T. Toki, K. Kogame, S. Takahashi, K. Igarashi, N. Hayashi, and M. Yamamoto. 1999. Molecular cloning and functional characterization of a new Cap'n' collar family transcription factor Nrf3. J. Biol. Chem. 274:6443-6452.
20. Kusunoki, H., H. Motohashi, F. Katsuoka, A. Morohashi, M. Yamamoto, and T. Tanaka. 2002. Solution structure of the DNA-binding domain of MafG. Nat. Struct. Biol. 9:252-256.[CrossRef][Medline]
21. Kwak, M. K., N. Wakabayashi, K. Itoh, H. Motohashi, M. Yamamoto, and T. W. Kensler. 2003. Modulation of gene expression by cancer chemopreventive dithiolethiones through the Keap1-Nrf2 pathway. Identification of novel gene clusters for cell survival. J. Biol. Chem. 278:8135-8145.
22. Leung, L., M. Kwong, S. Hou, C. Lee, and J. Y. Chan. 2003. Deficiency of the Nrf1 and Nrf2 transcription factors results in early embryonic lethality and severe oxidative stress. J. Biol. Chem. 278:48021-48029.
23. Li, W., M. R. Jain, C. Chen, X. Yue, V. Hebbar, R. Zhou, and A. N. Kong. 23 May 2005. NRF2 possesses a redox-insensitive nuclear export signal overlapping with the leucine zipper motif. J. Biol. Chem. doi:10.1074/jbc.M410601200.
24. McMahon, M., K. Itoh, M. Yamamoto, and J. D. Hayes. 2003. Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J. Biol. Chem. 278:21592-21600.
25. Moi, P., K. I. Chan, I. Asunis, A. Cao, and Y. W. Kan. 1994. Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the ß-globin locus control region. Proc. Natl. Acad. Sci. USA 91:9926-9930.
26. Moran, J. A., E. L. Dahl, and R. T. Mulcahy. 2002. Differential induction of mafF, mafG and mafK expression by electrophile-response-element activators. Biochem. J. 361:371-377.[CrossRef][Medline]
27. Motohashi, H., F. Katsuoka, J. D. Engel, and M. Yamamoto. 2004. Small Maf proteins serve as transcriptional cofactors for keratinocyte differentiation in the Keap1-Nrf2 regulatory pathway. Proc. Natl. Acad. Sci. USA 101:6379-6384.
28. Motohashi, H., F. Katsuoka, J. A. Shavit, J. D. Engel, and M. Yamamoto. 2000. Positive or negative MARE-dependent transcriptional regulation is determined by the abundance of small Maf proteins. Cell 103:865-875.[CrossRef][Medline]
29. Motohashi, H., T. O'Connor, F. Katsuoka, J. D. Engel, and M. Yamamoto. 2002. Integration and diversity of the regulatory network composed of Maf and CNC families of transcription factors. Gene 294:1-12.[CrossRef][Medline]
30. Motohashi, H., J. A. Shavit, K. Igarashi, M. Yamamoto, and J. D. Engel. 1997. The world according to Maf. Nucleic Acids Res. 25:2953-2959.
31. Newman, J. R., and A. E. Keating. 2003. Comprehensive identification of human bZIP interactions with coiled-coil arrays. Science 300:2097-2101.
32. Nguyen, T., H. C. Huang, and C. B. Pickett. 2000. Transcriptional regulation of the antioxidant response element. Activation by Nrf2 and repression by MafK. J. Biol. Chem. 275:15466-15473.
33. Nguyen, T., P. J. Sherratt, H. C. Huang, C. S. Yang, and C. B. Pickett. 2003. Increased protein stability as a mechanism that enhances Nrf2-mediated transcriptional activation of the antioxidant response element. Degradation of Nrf2 by the 26S proteasome. J. Biol. Chem. 278:4536-4541.
34. Nioi, P., M. McMahon, K. Itoh, M. Yamamoto, and J. D. Hayes. 2003. Identification of a novel Nrf2-regulated antioxidant response element (ARE) in the mouse NAD(P)H:quinone oxidoreductase 1 gene: reassessment of the ARE consensus sequence. Biochem. J. 374:337-348.[CrossRef][Medline]
35. Onodera, K., J. A. Shavit, H. Motohashi, F. Katsuoka, J. E. Akasaka, J. D. Engel, and M. Yamamoto. 1999. Characterization of the murine mafF gene. J. Biol. Chem. 274:21162-21169.
36. Onodera, K., J. A. Shavit, H. Motohashi, M. Yamamoto, and J. D. Engel. 2000. Perinatal synthetic lethality and hematopoietic defects in compound mafG::mafK mutant mice. EMBO J. 19:1335-1345.[CrossRef][Medline]
37. Oyake, T., K. Itoh, H. Motohashi, N. Hayashi, H. Hoshino, M. Nishizawa, M. Yamamoto, and K. Igarashi. 1996. Bach proteins belong to a novel family of BTB-basic leucine zipper transcription factors that interact with MafK and regulate transcription through the NF-E2 site. Mol. Cell. Biol. 16:6083-6095.[Abstract]
38. Rushmore, T. H., M. R. Morton, and C. B. Pickett. 1991. The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J. Biol. Chem. 266:11632-11639.
39. Shavit, J. A., H. Motohashi, K. Onodera, J. Akasaka, M. Yamamoto, and J. D. Engel. 1998. Impaired megakaryopoiesis and behavioral defects in mafG-null mutant mice. Genes Dev. 12:2164-2174.
40. Shivdasani, R. A., M. F. Rosenblatt, D. Zucker-Franklin, C. W. Jackson, P. Hunt, C. J. Saris, and S. H. Orkin. 1995. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development. Cell 81:695-704.[CrossRef][Medline]
41. Stewart, D., E. Killeen, R. Naquin, S. Alam, and J. Alam. 2003. Degradation of transcription factor Nrf2 via the ubiquitin-proteasome pathway and stabilization by cadmium. J. Biol. Chem. 278:2396-2402.
42. Sun, J., H. Hoshino, K. Takaku, O. Nakajima, A. Muto, H. Suzuki, S. Tashiro, S. Takahashi, S. Shibahara, J. Alam, M. M. Taketo, M. Yamamoto, and K. Igarashi. 2002. Hemoprotein Bach1 regulates enhancer availability of heme oxygenase-1 gene. EMBO J. 19:5216-5224.[CrossRef]
43. Wakabayashi, N., K. Itoh, J. Wakabayashi, H. Motohashi, S. Noda, S. Takahashi, S. Imakado, T. Kotsuji, F. Otsuka, D. R. Roop, T. Harada, J. D. Engel, and M. Yamamoto. 2003. Keap1-null mutation leads to postnatal lethality due to constitutive Nrf2 activation. Nat. Genet. 35:238-245.[CrossRef][Medline]
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|